Medicrit Biopharma Private Limited

Medicrit Biopharma Private Limited - construction in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U45309MH2021PTC358008 Incorporated 26 March 2021 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company construction MSME · Micro
Revenue · FY 2025
₹4.77 Cr
▲ 115% YoY
Net profit · FY 2025
₹2.91 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹5.39 Lakh
EBITDA margin 1.1%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Medicrit Biopharma Private Limited

Data last updated:

Medicrit Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the building installation services segment of the construction sector. It was incorporated on 26 March 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U45309MH2021PTC358008.

The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyanka Kumari and Rimjhim Rani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M/S Sai Prabhat Developers Shop No B – 116 Bhaskar Commercial Complex 2 Vasai, Mumbai, Maharashtra, India – 401303.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.77 Cr, a growth of 115% compared to the previous year. For the same year it recorded a net profit of ₹2.91 Lakh (net margin 0.6%) and EBITDA of ₹5.39 Lakh (EBITDA margin 1.1%).

Medicrit Biopharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0039685). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U45309MH2021PTC358008
Registration Number 358008
Incorporation Date 26 March 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0039685

Recognitions & Rankings of Medicrit Biopharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-BR-26-0039685

Contact details

Medicrit Biopharma Private Limited's registered office is in Mumbai, Maharashtra.

  • Registered Address
    M/S Sai Prabhat Developers Shop No B – 116 Bhaskar Commercial Complex 2 Vasai, Mumbai, Maharashtra, India – 401303
  • Industry
    Construction, Building Installation, Other Building Installation
Comprehensive company report
Medicrit Biopharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medicrit Biopharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles47Retail trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Medicrit Biopharma Private Limited, buy the company report.

Financials of Medicrit Biopharma Private Limited

FY 2025 filings available

Medicrit Biopharma Private Limited reported revenue of ₹4.77 Cr (up 115% YoY) for FY 2025.

Revenue · FY 2025
₹4.77 Cr ▲ 115%
Net profit · FY 2025
₹2.91 Lakh margin 0.6%
EBITDA · FY 2025
₹5.39 Lakh margin 1.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 115%
EBITDA CAGR growth
1 year
▲ 189%

Revenue rose 115% in the latest year. EBITDA rose 189% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.39 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.91 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.1%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medicrit Biopharma Private Limited, buy the company report.

Board of directors of Medicrit Biopharma Private Limited

Medicrit Biopharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Priyanka KumariDirector26 Mar 20215 Years 7 MonthsCurrent
Rimjhim RaniDirector26 Mar 20215 Years 7 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medicrit Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Medicrit Biopharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Medicrit Biopharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Priyanka Kumari was appointed as Director on 26 Mar 2021.

AGM
Medicrit Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medicrit Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Priyanka Kumari was appointed as Director.
Appointed
Rimjhim Rani was appointed as Director.
Incorporation
26 Mar 2021
Medicrit Biopharma Private Limited was registered on 26 Mar 2021 with Roc Mumbai I & aged 5 years 7 months as per MCA records.

Frequently asked questions

Medicrit Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in building installation, within the construction industry. It was incorporated on 26 March 2021 (5+ years old) and is registered under CIN U45309MH2021PTC358008.

Medicrit Biopharma has 2 current directors:

The latest financial statements of Medicrit Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Medicrit Biopharma is U45309MH2021PTC358008. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medicrit Biopharma was incorporated on 26 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

Priyanka Kumari was appointed as Director on 26 Mar 2021. Rimjhim Rani was appointed as Director on 26 Mar 2021.

Yes, Medicrit Biopharma is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0039685).

The registered office of Medicrit Biopharma is at MS Sai Prabhat Developers Shop No B – 116 Bhaskar Commercial Complex 2 Vasai, Mumbai, Maharashtra, India – 401303.

Medicrit Biopharma operates in the construction industry, in the building installation segment.

The compliance status of Medicrit Biopharma is compliant as of 01 July 2026. The company is actively filing with the Registrar of Companies.